Literature DB >> 1451234

Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.

L L Thomsen1, B C Baguley, W R Wilson.   

Abstract

Flavone-8-acetic acid (FAA) and its more dose-potent analogue 5,6-dimethylxanthenone-4-acetic acid (5,6-MeXAA), appear to exert their antitumor effects through vascular and other host-mediated mechanisms and are known to induce the synthesis of nitric oxide by murine macrophages. We investigated the role of nitric oxide in the cytotoxic effects of these drugs in host-cell-infiltrated spheroids. EMT6 murine mammary adenocarcinoma cells were grown in culture to produce multicellular spheroids in vitro spheroids), which were then inoculated i.p. into mice. After 6 days the spheroids were removed ex vivo spheroids). Exposure to FAA (890 microM) and 5,6-MeXAA (80 microM) in vitro for 20 h increased nitrite concentrations to 6.7 and 9.7 nmol/spheroid, respectively, as compared with 0.7 nmol/spheroid in the absence of drug. FAA and 5,6-MeXAA did not increase nitrite production in in vitro spheroids in cells obtained by peritoneal lavage. However, mixed cultures of in vitro spheroids and peritoneal cells treated with 5,6-MeXAA produced nitrite (2.4 nmol/spheroid), indicating that interactions between host cells and tumour cells were important for induction. The effects of these drugs on ex vivo spheroids were prevented by co-incubation with NG-monomethyl-L-arginine, indicating that nitrite originated from the oxidation of L-arginine to nitric oxide. Cell sorting of disaggregated spheroids into EMT6 cells and Mac-1-positive macrophage populations indicated that both of these cell populations could be induced to synthesise nitric oxide by subsequent incubation with 5,6-MeXAA. Incubation of ex vivo spheroids with FAA and 5,6-MeXAA decreased the clonogenicity of EMT6 cells, and this effect was wholly (FAA) or partially (5,6-MeXAA) reversed by the presence of NG-monomethylarginine (250 microM). FAA and 5,6-MeXAA may therefore exert some of their cytotoxic effects on tumour cells through the production of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451234     DOI: 10.1007/bf00685103

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  24 in total

1.  L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages.

Authors:  R Keller; M Geiges; R Keist
Journal:  Cancer Res       Date:  1990-03-01       Impact factor: 12.701

2.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

3.  Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown.

Authors:  V Mahadevan; S T Malik; A Meager; W Fiers; G P Lewis; I R Hart
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

4.  Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo.

Authors:  G W Rewcastle; G J Atwell; B C Baguley; S B Calveley; W A Denny
Journal:  J Med Chem       Date:  1989-04       Impact factor: 7.446

5.  Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells.

Authors:  L M Li; R G Kilbourn; J Adams; I J Fidler
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

6.  Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives.

Authors:  H Futami; L Eader; T T Back; E Gruys; H A Young; R H Wiltrout; B C Baguley
Journal:  J Immunother (1991)       Date:  1992-11

7.  Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.

Authors:  J C Drapier; J Wietzerbin; J B Hibbs
Journal:  Eur J Immunol       Date:  1988-10       Impact factor: 5.532

8.  Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.

Authors:  J Plowman; V L Narayanan; D Dykes; E Szarvasi; P Briet; O C Yoder; K D Paull
Journal:  Cancer Treat Rep       Date:  1986-05

9.  Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.

Authors:  J L Evelhoch; M C Bissery; G G Chabot; N E Simpson; C L McCoy; L K Heilbrun; T H Corbett
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

10.  Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.

Authors:  E M Lord
Journal:  Br J Cancer Suppl       Date:  1980-04
View more
  1 in total

1.  The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts.

Authors:  Dušan Milanović; Friederike Braun; Wolfgang Weber; Anca Ligia Grosu; Martin Behe; Gabriele Niedermann
Journal:  BMC Cancer       Date:  2012-06-13       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.